| Database ID | Agent | Target | Cancer Type | Detail |
| DB00046 | dasatinib | Protooncogene tyrosineprotein kinase SRC
Abl
Protooncogene tyrosineprotein kinase LCK
Protooncogene tyrosineprotein kinase Fyn | prostate cancer | view |
| DB00047 | vemurafenib | BRaf protooncogene
serine/threonineprotein kinase | colorectal cancer | view |
| DB00048 | dabrafenib | BRaf protooncogene serine/threonineprotein kinase | colorectal cancer | view |
| DB00049 | bevacizumab | Vascular endothelial growth factor | colorectal cancer | view |
| DB00050 | pembrolizumab | The antiprogrammeddeathreceptor1 | melanoma | view |
| DB00051 | gefitinib | Epidermal growth factor receptor | advanced solid tumors | view |
| DB00052 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00053 | gefitinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00054 | gefitinib | Epidermal growth factor receptor | lung cancer | view |
| DB00055 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00056 | erlotinib | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00057 | afatinib | Receptor proteintyrosine kinase erbB2
Epidermal growth factor receptor | lung cancer | view |
| DB00058 | afatinib | Receptor proteintyrosine kinase erbB2
Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00059 | afatinib | Receptor proteintyrosine kinase erbB2
Epidermal growth factor receptor | lung cancer | view |
| DB00060 | afatinib | Receptor proteintyrosine kinase erbB2
Epidermal growth factor receptor | lung cancer | view |